Omeprazol Terapia (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Terapia, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adults, such as gastro‑esophageal reflux disease and peptic ulcer disease.

GNH USA supplies Omeprazol Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Omeprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related conditions.

- Gastro‑esophageal reflux disease (GERD): relieves heartburn and esophagitis by decreasing gastric acid exposure. - Peptic ulcer disease: promotes ulcer healing by maintaining a less acidic gastric environment. - NSAID‑induced gastric ulcer: protects the stomach lining when non‑steroidal anti‑inflammatory drugs are used. - Zollinger‑Ellison syndrome: controls excessive acid production caused by gastrin‑secreting tumors.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Abdominal pain: discomfort or cramping. - Nausea: feeling of queasiness. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Severe allergic reactions: rash, swelling, anaphylaxis. - Stevens‑Johnson syndrome: skin blistering. - Elevated liver enzymes: possible hepatic injury. - Hypomagnesemia: low magnesium levels with prolonged use. - Bone fracture risk: decreased calcium absorption over long term.

Before initiating therapy, consider the following safety measures.

- Assess renal and hepatic function: adjust use if impairment is present. - Monitor for infections: prolonged acid suppression may increase risk of gastrointestinal infections. - Avoid abrupt discontinuation: taper to prevent rebound acid hypersecretion. - Use lowest effective dose: limit duration to the shortest period necessary. - Review concomitant medications: evaluate for potential interactions. - Store at room temperature (below 25°C): keep in the original container, protect from moisture and light.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activation, increasing cardiovascular risk. - Atazanavir (HIV protease inhibitor): markedly decreased plasma concentrations, compromising antiviral efficacy. - Methotrexate (high dose): increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Phenytoin: decreased serum levels, potentially reducing seizure control. - Iron supplements: reduced iron absorption; separate dosing by at least 2 hours.